Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed the potential of a respiratory syncytial virus vaccine in children, as well as ongoing efforts to get childhood vaccination rates back on track.
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed whether respiratory syncytial virus (RSV) vaccines could become part of the immunization schedule and how her practice is addressing immunization rates in children.
Transcript
When RSV vaccines for infants do become available in the United States, are you expecting them to be included on the childhood immunization schedule? What will families need to know?
So I think that really comes down to what that looks like, how effective it is. I think if there's broad public health implications, and of course, if we can keep an infant from getting seriously ill, then I can see it potentially definitely getting connected or getting added to the plethora of infant vaccines that we give. Honestly, I think we’ve got to wait and see what it looks like and the timing.
How is your practice working to try and get families back on track with childhood immunizations?
So, I think that you're absolutely right, we did fall behind on not just COVID-19 and flu vaccinations but other childhood vaccines. So, it's a process approach and it's an individual approach. From a process approach, our practice is reaching out to children who aren't fully immunized and trying to get them in and working with parents to be flexible on how to do that. We approach any child that comes in for a sick visit, even, and we always review immunizations during that time. You know, the harder decision or the harder challenges [are] for families who've chosen not to immunize their children across the board and that is ongoing conversations about trust and dispelling myths, and that is sometimes a very long haul. And that was prepandemic, but I do think that the pandemic has worsened some of that.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More